NKG2D was not downregulated on peripheral NK or CD8 T cells in the context of detectable ULBP1, but may have been affected within the tumor micro-environment, where NKG2D is known to be significantly downregulated (23). The gene discussed is ULBP1; the disease is neoplasm.